Hungaropharma Zrt. acquired the 100% shareholding in QB-Pharma Kft on 19 March 2018.
QB-Pharma Kft. is the first cloud-based computer software development and operation company in the market of public pharmacy computer software systems.
The Company was formed in February 2018 by the divestment of the pharmacy division of Quadro-Byte Zrt. Systems developed by QB-Pharma have provided comprehensive, effective IT solutions for pharmacies and patient care institutions for 25 years. Following the transaction, QB-Pharma will continue to operate independently, with its previous management and employees.
Hungaropharma Zrt. is the largest player in the Hungarian pharmaceutical wholesale market with its 40% market share. Over 2,400 pharmacies and around 140 hospitals are serviced by them throughout the country and they sell nearly 135 million boxes of pharmaceuticals and other medicinal products annually.
With the acquisition of QB-Pharma Kft., Hungaropharma Zrt entered a new sector of the pharmaceutical industry through a significant market player, with a view to expanding its services to pharmacies and maintaining a competitive position in service provision the market of pharmacy sytem administrators as a capital-intensitve professional investor.
Concorde MB Partners Kft. Was the exclusive financial advisor to Hungaropharma Zrt. supporting it throughout the whole process, including the divestment of QB-Pharma Kft. from Quadro-Byte Zrt.
